Hepatitis-C-Update-2 |
16267758 |
Risk factors for perinatal transmission of
hepatitis C virus (HCV) and the natural history of HCV infection
acquired in infancy. |
Cohort Study |
Cohort studies predictive score below
threshold |
Error
|
Hepatitis-C-Update-2 |
22813094 |
Comparison of current US risk strategy to
screen for hepatitis C virus with a hypothetical targeted birth
cohort strategy. |
Comparative study; birth cohort
strategy |
Cohort studies predictive score below
threshold |
Error
|
Long-Acting-Insulins |
22966091 |
Does insulin glargine increase the risk of
cancer compared with other basal insulins?: A French nationwide
cohort study based on national administrative databases. |
Cohort Study |
Cohort studies predictive score below
threshold |
Error
|
MS-Drugs-Update-3 |
19936821 |
Parenthood and immunomodulation in
patients with multiple sclerosis. |
Cohort Study |
Cohort studies predictive score below
threshold |
Error
|
MS-Drugs-Update-3 |
24131589 |
Prevalence of cutaneous adverse events
associated with long-term disease-modifying therapy and their impact
on health-related quality of life in patients with multiple
sclerosis: a cross-sectional study. |
Cross-Sectional Study |
Cross-Sectional Study tagger not used |
Exception
|
MS-Drugs-Update-3 |
24463630 |
Pregnancy outcomes in the clinical
development program of fingolimod in multiple sclerosis. |
Clinical Study |
Clinical Study predictive score below
threshold |
Error
|
Newer-Diabetes-Meds-Update-2 |
25300980 |
Drug utilization, safety, and
effectiveness of exenatide, sitagliptin, and vildagliptin for type 2
diabetes in the real world: data from the Italian AIFA
Anti-diabetics Monitoring Registry. |
Retrospective cohort study |
Cohort studies predictive score below
threshold |
Error
|